Home › Squamous Cell Carcinoma › Georgia › Atlanta
Squamous Cell Carcinoma clinical trials in Atlanta, GA
4 studies for Squamous Cell Carcinoma are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RecruitingPhase 3
- Emory University Hospital Midtown, Atlanta
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
RecruitingPhase 2
- Winship Cancer Institute at Emory University, Atlanta
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
Recruiting
- Emory University, Atlanta
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- Emory University, Atlanta
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA11 studies
- Los Angeles, CA9 studies
- Nashville, TN8 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Houston, TX7 studies
- Durham, NC6 studies
- St. Louis, MO6 studies
- San Diego, CA6 studies
- Chicago, IL5 studies
- Queens, NY4 studies
- Washington, DC4 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer48 studies
- Multiple Myeloma42 studies
- Breast Cancer42 studies
- Prostate Cancer36 studies
- Acute Myeloid Leukemia30 studies
- Metastatic Cancer29 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer28 studies
- Obesity26 studies
- Major Depressive Disorder24 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.